Brenda Winski, NP
Nurse Practitioner · Michigan City, INNPI 1174711618
Payments from drug & device makers
Across 284 payments — averaging $19.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$951
- Sun Pharmaceutical Industries Inc.$497
- Johnson & Johnson$477
- Amgen$447
- Pfizer$397
- Novartis$396
- plus $2K from 20 others
What the payments were for
- Food & beverage$5,17195%
- Education$2945%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 58 | $951 |
| Sun Pharmaceutical Industries Inc. | 36 | $497 |
| Johnson & Johnson | 13 | $477 |
| Amgen | 26 | $447 |
| Pfizer | 22 | $397 |
| Novartis | 20 | $396 |
| E.r. Squibb & Sons, L.L.C. | 12 | $288 |
| Galderma Laboratories, L.p. | 12 | $276 |
| Sanofi | 11 | $259 |
| Lilly USA, LLC | 13 | $258 |
| Regeneron Healthcare Solutions, Inc. | 10 | $237 |
| UCB, Inc. | 7 | $187 |
| LEO Pharma Inc. | 5 | $133 |
| Incyte Corporation | 6 | $104 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 5 | $95 |
| Biofrontera Inc. | 5 | $93 |
| Dermavant Sciences, Inc. | 5 | $84 |
| Organon | 7 | $76 |
| Almirall LLC | 3 | $58 |
| VYNE Pharmaceuticals Inc. | 2 | $32 |
| Journey Medical Corporation | 1 | $28 |
| Botanix SB Inc | 1 | $23 |
| Boehringer Ingelheim | 1 | $19 |
| Qiagen, LLC | 1 | $19 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $18 |
| Verrica Pharmaceuticals Inc. | 1 | $13 |
How this compares
$5,465 in reported general payments places this provider in the 95th percentile of 2,724 nurse practitioner providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluorouracil | 21 | $1,538 |
| Ketoconazole | 55 | $710 |
| Triamcinolone Acetonide | 68 | $363 |
| Mupirocin | 40 | $288 |
| Doxycycline Hyclate | 15 | $215 |
| Hydrocortisone | 22 | $103 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Michigan City
- Kayla SpearsMichigan City$10K
- Kristi OrbaughIndianapolis$1.3M
- Kimberly EadsPlainfield$302K
- Sean GoddardFort Wayne$180K
- Kacy RogersIndianapolis$77K
- Kristine TaylorFort Wayne$69K
- Brittany SavageIndianapolis$51K
- Monica HaugerTrafalgar$47K
- Rhonda HettingerClarksville$38K
- Jennifer MaahsIndianapolis$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.